4-Chloro-7-fluoro-2-methylquinazoline, 95.0%, 250mg

1-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)pyrrolidine, 95%, 5g

Hydroxyde de sodium, min 98 %, pa, ISO, en pastilles, 2,5 kg, emballage plastique.

4-Bromo-6-fluoro-1H-indazole, 95.0%, 1g

2-Amino-3-hydroxybenzoic acid, 95.0%, 10g

(3R)-(+)-3-(Trifluoroacetamido)pyrrolidine Hydrochloride>98.0%(T)25g

3-Acetyl-4-methoxybenzonitrile, 97%, 100mg

1-tert-butyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate, 97.0%, 10g

(S)-1-Boc-3-Hydroxymethyl-pyrrolidine, 96.0%, 1g

Ethyl 7-Chloroimidazo[1,2-a]pyridine-2-carboxylate, 97.0%, 10g

2-methyl-N-(4-methylbenzyl)-1-propanamine hydrochloride, 95.0%, 10g

Monastrol, 99.70%, 100mg

Dasotraline hydrochloride, 99.74%, 100mg